This medicinal cannabis website bends the rules. Take our quiz to see why
Many medicinal cannabis websites fail to meet medicinal cannabis website compliance standards, leading to misleading health claims. This can misinform patients and undermine evidence-based prescribing. Clinicians must guide patients to reliable,…
Missouri Attorney General Issues Warning on Unsafe Cannabis Products
The Missouri cannabis product safety warning issued by the attorney general highlights risks from unlicensed cannabis products. These products often have inaccurate labeling and pose safety concerns. Clinicians should counsel patients to purchase only…
Senator Pushes Back on Proposed Regulations for Consumable Hemp Products
The hemp-derived cannabinoid market is currently facing significant regulatory uncertainty. This impacts product testing, labeling, and potency standards, complicating patient safety guidance. Clinicians must understand these challenges to better counsel…
India Issues First Cannabis Research Grant That Could Help Open Up Market
India cannabis research grant represents a major policy shift toward standardized medical cannabis products. This grant could improve access to quality-controlled cannabis for clinicians and patients. The initiative may pave the way for regulated medical…
Bridging the Gap: What Integrated Care Really Means for Patients with Complex Needs
Integrated care models cannabis are essential for coordinating treatment in patients with complex needs. These models reduce risks of drug interactions and improve patient safety. Clinicians must adopt integrated cannabis care to optimize therapeutic…
Artelo Expands Glaucoma Research with CB2 Receptor Targeting Study
This study on cb2 receptor targeting glaucoma explores cannabinoid compounds as alternative treatments for patients with limited options. Artelo's funded research focuses on the endocannabinoid system's role in managing intraocular pressure. The findings…
Artelo Biosciences Advances Cannabinoid-Based Glaucoma Treatments
Cannabinoid-based glaucoma treatments represent a novel approach targeting intraocular pressure reduction through endocannabinoid signaling. This fully funded study by Artelo Biosciences explores therapeutic potential beyond conventional options.…
Medicinal Cannabis Goes Mainstream but Australia Struggles to Cope
The Cannabinoid Clinical Research Excellence centre is addressing critical gaps in Australia's medicinal cannabis sector. Clinicians need clear evidence-based guidance to safely prescribe cannabis therapies. This focus on cannabinoid clinical research…
Cannabis Can Blur and Reshape Your Memory, Study Finds
Cannabis-induced memory dysfunction affects how memories are formed and recalled. This clinical insight highlights the importance of assessing memory in cannabis users. Understanding these effects helps clinicians manage cognitive complaints effectively.
Cannabis May Backfire for Mental Health Disorders, Major Study Finds
Recent studies reveal cannabis use disorder strongly linked to major depression, emphasizing potential mental health risks. Modern high-potency cannabis may worsen anxiety and depression symptoms. Clinicians should counsel patients on these risks for…
